Data Characteristics
Bioequivalence (BE) study data primarily comes from clinical trial reports, pharmacokinetic (PK) analysis reports, statistical analysis reports, and regulatory review documents. This data updates infrequently, typically with new drug applications or generic drug consistency evaluation projects. Document structures are mainly structured reports, containing numerous tables, charts, and statistical data. Key fields include drug name, active ingredient, dosage form, strength, administration route, study design, subject information, plasma concentration-time curve data (e.g., AUC, Cmax, Tmax), statistical analysis results (e.g., geometric mean ratio and its 90% confidence interval), bioanalytical methods, adverse event (AE) incidence, and severity. Units involve concentration (ng/mL, μg/mL), time (h), dose (mg), and statistical parameters (%), requiring high precision.
Constraints on Citation and Traceability
The structured nature of bioequivalence data requires citation parsing to focus on specific sections and tables within reports. Due to infrequent data updates, knowledge base construction can use a strategy of periodic full updates combined with incremental corrections to ensure data timeliness. Chart information, such as plasma concentration-time curves, requires the AI model to have image content understanding or chart metadata extraction capabilities for accurate original chart referencing during citation traceability. The precision requirement for statistical parameters means the model must identify and precisely extract numerical values, linking them to corresponding statistical methods and confidence intervals. The presence of adverse event data means that citations must trace back to the original report and further refine to specific event descriptions and frequencies, supporting precise pharmacovigilance judgments.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size | 500–800 characters | Clinical report paragraphs are often long, containing multiple key pieces of information. Shorter segments would break context; longer segments reduce retrieval efficiency. |
Recall count | 8–12 entries | Bioequivalence reports contain many details. Increasing the number of recalled items helps cover more relevant but not directly matched information. |
Similarity threshold | 0.75–0.85 | Ensures the precision of recalled content, avoiding the introduction of irrelevant statistical data or adverse event descriptions. |
Rerank result count | 3–5 entries | After reranking, focus on the most relevant citations to improve the quality and readability of the final presentation. |
maxContext | 4096 tokens | Ensures enough context information can be accommodated, especially for paragraphs containing complex statistical tables. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Provides sufficient parsing time when processing large PDF report files, preventing file processing failures due to timeouts. |
Common Pitfalls
- Citations contain incomplete or incorrect data units because the text parser fails to correctly identify and extract unit information next to numerical values.
- Knowledge base citations point to irrelevant clinical trials or drugs because the
Similarity threshold(similarity threshold) is set too low, recalling semantically similar but factually mismatched document segments. - The conversation cannot trace back to the specific frequency of an adverse event because the numerical field for adverse events was not marked as searchable or was not structurally extracted during knowledge base construction.
Validation Steps
- Select typical queries from multiple bioequivalence reports. Check if citations accurately point to specific sections, tables, or paragraphs in the original report.
- For queries involving key parameters such as plasma concentration, AUC, and Cmax, verify that the numerical values and units extracted in the citation match those in the original report.
- Simulate questions about adverse events. Verify that citations accurately link to adverse event descriptions and statistical data in the report.
- Test queries on similar drugs or different batches of reports. Confirm that citation content can differentiate and point to the correct drug or trial data.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.